BRPI1014579A2 - método de transferência de polipeptídeo para células - Google Patents

método de transferência de polipeptídeo para células

Info

Publication number
BRPI1014579A2
BRPI1014579A2 BRPI1014579A BRPI1014579A BRPI1014579A2 BR PI1014579 A2 BRPI1014579 A2 BR PI1014579A2 BR PI1014579 A BRPI1014579 A BR PI1014579A BR PI1014579 A BRPI1014579 A BR PI1014579A BR PI1014579 A2 BRPI1014579 A2 BR PI1014579A2
Authority
BR
Brazil
Prior art keywords
cells
transfer method
polypeptide transfer
polypeptide
transfer
Prior art date
Application number
BRPI1014579A
Other languages
English (en)
Inventor
Katrin Edmaier
Ludwig Deml
Sascha Barabas
Original Assignee
Lophius Biosciences Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lophius Biosciences Gmbh filed Critical Lophius Biosciences Gmbh
Publication of BRPI1014579A2 publication Critical patent/BRPI1014579A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
BRPI1014579A 2009-04-09 2010-04-09 método de transferência de polipeptídeo para células BRPI1014579A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157777A EP2239569A1 (en) 2009-04-09 2009-04-09 Method for polypeptide transfer into cells
PCT/EP2010/054711 WO2010115984A1 (en) 2009-04-09 2010-04-09 Method for polypeptide transfer into cells

Publications (1)

Publication Number Publication Date
BRPI1014579A2 true BRPI1014579A2 (pt) 2016-04-26

Family

ID=40974538

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014579A BRPI1014579A2 (pt) 2009-04-09 2010-04-09 método de transferência de polipeptídeo para células

Country Status (11)

Country Link
US (2) US9476878B2 (pt)
EP (2) EP2239569A1 (pt)
KR (1) KR101835647B1 (pt)
CN (1) CN102460161B (pt)
AU (1) AU2010233668B2 (pt)
BR (1) BRPI1014579A2 (pt)
CA (1) CA2758159C (pt)
EA (1) EA020583B1 (pt)
ES (1) ES2653561T3 (pt)
SG (2) SG175153A1 (pt)
WO (1) WO2010115984A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012068474A2 (en) * 2010-11-19 2012-05-24 Rutgers, The State University Of New Jersey A high-throughput asseessment method for contact hypersensitivity
WO2013166297A2 (en) * 2012-05-03 2013-11-07 Medimmune, Llc Method for analyzing sample components
CN103235135B (zh) * 2013-04-26 2015-02-04 史其新 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用
CN104031125B (zh) * 2014-06-27 2016-10-05 顾玉奎 自然杀伤t细胞活化剂多肽及其应用
CN104031126B (zh) * 2014-06-27 2016-10-12 顾玉奎 一种自然杀伤t细胞活化剂多肽及其应用
US20180267024A1 (en) * 2015-06-08 2018-09-20 Lophius Biosciences Gmbh Composition for determination of cell-mediated immune responsiveness
CN106011060A (zh) * 2016-06-29 2016-10-12 北京中台恒基生物技术有限公司 一种体外激活和扩增nkt样细胞的方法
TW202334184A (zh) * 2021-11-10 2023-09-01 日商長瀨產業股份有限公司 SapB蛋白質之修飾體、SapB蛋白質及其修飾體之配製方法,以及溶解SapB蛋白質或其修飾體之水溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128005A (en) 1966-04-01 1968-09-25 Medimpex Gyogyszerkulkereskede Improvements in or relating to antigenic and allergenic preparations
FR2633518B1 (fr) 1988-06-30 1991-03-22 Merieux Inst Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues
IT1237475B (it) 1989-10-06 1993-06-07 Allergeni modificati chimicamente e procedimento per la loro preparazione
JPH08511007A (ja) 1993-06-09 1996-11-19 コノート ラボラトリーズ リミテッド タンデム合成hiv−1ペプチド
EP0638593A1 (en) * 1993-08-02 1995-02-15 Shell Internationale Researchmaatschappij B.V. Catalyst compositions
US6977073B1 (en) * 1997-02-07 2005-12-20 Cem Cezayirli Method for stimulating an immune response
JP2002512808A (ja) 1998-04-28 2002-05-08 ワシントン ユニバーシティー 融合タンパク質の形質導入法
DE10212867B4 (de) 2002-03-22 2005-07-21 Hans Prof. Dr. Wolf Verwendung Harnstoff-adjuvierter Polypeptide zur Diagnose, Prophylaxe und Therapie
DE602007001273D1 (de) * 2007-02-22 2009-07-23 Polymun Scient Immunbio Forsch Erythropoetinfusionsprotein
CN104031393B (zh) * 2008-06-18 2017-08-01 生命连结有限公司 改进的交联组合物

Also Published As

Publication number Publication date
CA2758159C (en) 2017-03-14
EP2239569A1 (en) 2010-10-13
AU2010233668A1 (en) 2011-10-13
EA020583B1 (ru) 2014-12-30
SG175153A1 (en) 2011-11-28
WO2010115984A1 (en) 2010-10-14
US20120093872A1 (en) 2012-04-19
US9850464B2 (en) 2017-12-26
SG10201401126QA (en) 2014-10-30
AU2010233668B2 (en) 2014-07-17
EP2417451B1 (en) 2017-09-27
US20170058260A1 (en) 2017-03-02
EP2417451A1 (en) 2012-02-15
KR20120013373A (ko) 2012-02-14
EA201171232A1 (ru) 2012-05-30
KR101835647B1 (ko) 2018-03-08
CA2758159A1 (en) 2010-10-14
CN102460161A (zh) 2012-05-16
US9476878B2 (en) 2016-10-25
ES2653561T3 (es) 2018-02-07
CN102460161B (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
BRPI1010035A2 (pt) Células deficientes em fucosilação
BRPI1009871A2 (pt) terapia para promover o crescimento celular
DE10836288T8 (de) Schwimmendes Stromkraftwerk
PL2454416T5 (pl) Powierzchnie wykorzystujące moduły strukturalne
PT2299499E (pt) Unidade fotovoltaica flutuante
BRPI1009416A2 (pt) célula solar.
PL2475737T3 (pl) Sposób przenoszenia ciepła
BRPI1010146A2 (pt) telha fotovoltaica para telhado
DK2448963T3 (da) T-celle receptorer
EP3719852C0 (en) SOLAR CELL
EP2408057A4 (en) Dye-sensitized solar cell
EP2626910A4 (en) PHOTOVOLTAIC CELL
PT2612390T (pt) Unidade para célula de combustível reversível
EP2467882A4 (en) SOLAR CELL
BRPI1011394A8 (pt) método para avaliação de responsividade de linforma de células b ao tratamento com anticorpos anti-cd40
BR112013016341A2 (pt) método de congelamento de células
EP2501017A4 (en) POWER SUPPLY SYSTEM
ES2453203B1 (es) Concentrador solar
EP2395565A4 (en) SOLAR CELL
BRPI1014093A2 (pt) método para evitar perda de líquido, e, coletor de fração
EP2386124A4 (en) SOLAR CELL
IT1395180B1 (it) Apparato per trasferire oggetti
SG10201401126QA (en) Method for polypeptide transfer into cells
DE112010003235A5 (de) Solarkonzentrator
BR112012022525A2 (pt) método para produzir butanol

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL